Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

LYNGBY FYSIOTERAPI, KLINIK FOR FYSIOTERAPI ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   1.4% 1.4% 1.8% 1.3% 2.2% 1.2% 9.8% 9.8%   Credit score (0-100)   81 79 71 78 66 80 25 25   Credit rating   A A A A BBB A BB BB   Credit limit (kDKK)   39.5 30.7 1.5 47.0 0.1 101.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,284 1,181 774 930 835 1,546 0.0 0.0   EBITDA   602 698 374 446 132 622 0.0 0.0   EBIT   581 677 270 310 -18.8 467 0.0 0.0   Pre-tax profit (PTP)   548.6 687.9 261.9 328.3 -129.2 511.7 0.0 0.0   Net earnings   425.8 533.6 206.3 256.1 -126.9 424.5 0.0 0.0   Pre-tax profit without non-rec. items   549 688 262 328 -129 512 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   52.6 31.6 539 403 413 304 0.0 0.0   Shareholders equity total   2,672 2,805 3,012 3,155 2,914 3,220 2,973 2,973   Interest-bearing liabilities   0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,878 3,015 3,223 3,329 3,010 3,429 2,973 2,973   Net Debt   -2,369 -2,243 -1,614 -1,844 -2,003 -2,479 -2,973 -2,973     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,284 1,181 774 930 835 1,546 0.0 0.0   Gross profit growth   -5.6% -8.0% -34.5% 20.2% -10.2% 85.2% -100.0% 0.0%   Employees   0 0 1 1 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 100.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,878 3,015 3,223 3,329 3,010 3,429 2,973 2,973   Balance sheet change%   1.3% 4.8% 6.9% 3.3% -9.6% 13.9% -13.3% 0.0%   Added value   601.7 698.4 373.9 446.0 116.9 622.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -20 -42 404 -271 -142 -263 -304 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   45.2% 57.4% 34.9% 33.4% -2.2% 30.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   21.2% 24.2% 9.2% 10.3% -0.1% 16.0% 0.0% 0.0%   ROI %   22.8% 26.1% 9.9% 11.0% -0.1% 16.7% 0.0% 0.0%   ROE %   16.0% 19.5% 7.1% 8.3% -4.2% 13.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   92.8% 93.1% 93.5% 94.8% 96.8% 93.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -393.7% -321.1% -431.6% -413.5% -1,517.5% -398.5% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 44,351.3% 20,928.6% 17,675.6% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   13.4 13.1 12.1 16.0 25.0 14.6 0.0 0.0   Current Ratio   13.4 13.1 12.1 16.0 25.0 14.6 0.0 0.0   Cash and cash equivalent   2,369.2 2,242.8 1,613.9 1,844.3 2,003.4 2,478.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,826.1 2,083.2 1,857.7 1,821.2 1,682.0 2,054.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 374 446 58 311 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 374 446 66 311 0 0   EBIT / employee   0 0 270 310 -9 233 0 0   Net earnings / employee   0 0 206 256 -63 212 0 0